{"result": "(\"entity\"<|>GOLDMAN JM<|>PERSON<|>Goldman JM is a researcher who has contributed to studies on allogenic and autologous transplantation for hematological diseases.)\n##\n(\"entity\"<|>SCHMITZ N<|>PERSON<|>Schmitz N is a researcher involved in the study of transplantation for hematological diseases and solid tumors.)\n##\n(\"entity\"<|>NIETHAMMER D<|>PERSON<|>Niethammer D is a researcher who has worked on transplantation procedures and their outcomes.)\n##\n(\"entity\"<|>GRATWOHL A<|>PERSON<|>Gratwohl A is a researcher focused on hematopoietic stem cell transplantation and its complications.)\n##\n(\"entity\"<|>ALLEN SJ<|>PERSON<|>Allen SJ is a researcher who has studied probiotics for treating infectious diarrhea in patients.)\n##\n(\"entity\"<|>OKOKO B<|>PERSON<|>Okoko B is a researcher involved in the study of probiotics and their efficacy in treating infections.)\n##\n(\"entity\"<|>MARTÍNEZ E<|>PERSON<|>Martínez E is a researcher who has contributed to studies on nutritional support in hematological patients.)\n##\n(\"entity\"<|>GREGORIO G<|>PERSON<|>Gregorio G is a researcher focused on nutritional challenges in hematopoietic stem cell transplant patients.)\n##\n(\"entity\"<|>DANS LF<|>PERSON<|>Dans LF is a researcher who has investigated nutritional support in pediatric cancer patients.)\n##\n(\"entity\"<|>YOUNG M<|>PERSON<|>Young M is a researcher who has reported on the efficacy of nasogastric feeding in transplant patients.)\n##\n(\"entity\"<|>STANFORD J<|>PERSON<|>Stanford J is a researcher involved in studies related to nutritional support in hematological patients.)\n##\n(\"entity\"<|>WALKER DJ<|>PERSON<|>Walker DJ is a researcher who has contributed to studies on nutritional challenges in transplant patients.)\n##\n(\"entity\"<|>FROST G<|>PERSON<|>Frost G is a researcher focused on nutritional support in patients undergoing transplantation.)\n##\n(\"entity\"<|>BOUNOUS G<|>PERSON<|>Bounous G is a researcher who has studied dietary protection during radiation therapy.)\n##\n(\"entity\"<|>IE BEL E<|>PERSON<|>Ie Bel E is a researcher involved in studies on nutritional support during chemotherapy.)\n##\n(\"entity\"<|>SHUSTER J<|>PERSON<|>Shuster J is a researcher who has worked on nutritional interventions in pediatric cancer.)\n##\n(\"entity\"<|>DONALDSON SS<|>PERSON<|>Donaldson SS is a researcher focused on nutritional support as an adjunct to radiation therapy.)\n##\n(\"entity\"<|>SEFCICK A<|>PERSON<|>Sefcick A is a researcher who has studied naso-jejunal feeding in transplant recipients.)\n##\n(\"relationship\"<|>GOLDMAN JM<|>MARROW TRANSPLANT GROUP<|>Goldman JM has contributed research findings to the Marrow Transplant Group regarding transplantation practices<|>6)\n##\n(\"relationship\"<|>SCHMITZ N<|>MARROW TRANSPLANT GROUP<|>Schmitz N has collaborated with the Marrow Transplant Group on studies related to hematological diseases<|>6)\n##\n(\"relationship\"<|>NIETHAMMER D<|>MARROW TRANSPLANT GROUP<|>Niethammer D has provided research insights to the Marrow Transplant Group on transplantation outcomes<|>6)\n##\n(\"relationship\"<|>GRATWOHL A<|>MARROW TRANSPLANT GROUP<|>Gratwohl A has worked with the Marrow Transplant Group on guidelines for stem cell transplantation<|>6)\n##\n(\"relationship\"<|>ALLEN SJ<|>MARROW TRANSPLANT GROUP<|>Allen SJ has contributed to the Marrow Transplant Group's research on nutritional support in transplant patients<|>6)\n##\n(\"relationship\"<|>OKOKO B<|>MARROW TRANSPLANT GROUP<|>Okoko B has collaborated with the Marrow Transplant Group on studies regarding probiotics<|>6)\n##\n(\"relationship\"<|>MARTÍNEZ E<|>MARROW TRANSPLANT GROUP<|>Martínez E has provided research findings to the Marrow Transplant Group on nutritional practices<|>6)\n##\n(\"relationship\"<|>GREGORIO G<|>MARROW TRANSPLANT GROUP<|>Gregorio G has worked with the Marrow Transplant Group on nutritional challenges in hematopoietic stem cell transplantation<|>6)\n##\n(\"relationship\"<|>DANS LF<|>MARROW TRANSPLANT GROUP<|>Dans LF has contributed to the Marrow Transplant Group's research on pediatric cancer nutrition<|>6)\n##\n(\"relationship\"<|>YOUNG M<|>MARROW TRANSPLANT GROUP<|>Young M has collaborated with the Marrow Transplant Group on nasogastric feeding studies<|>6)\n##\n(\"relationship\"<|>STANFORD J<|>MARROW TRANSPLANT GROUP<|>Stanford J has provided insights to the Marrow Transplant Group on nutritional support<|>6)\n##\n(\"relationship\"<|>WALKER DJ<|>MARROW TRANSPLANT GROUP<|>Walker DJ has contributed research findings to the Marrow Transplant Group on nutritional challenges<|>6)\n##\n(\"relationship\"<|>FROST G<|>MARROW TRANSPLANT GROUP<|>Frost G has collaborated with the Marrow Transplant Group on nutritional support studies<|>6)\n##\n(\"relationship\"<|>BOUNOUS G<|>MARROW TRANSPLANT GROUP<|>Bounous G has provided research insights to the Marrow Transplant Group on dietary protection<|>6)\n##\n(\"relationship\"<|>IE BEL E<|>MARROW TRANSPLANT GROUP<|>Ie Bel E has collaborated with the Marrow Transplant Group on nutritional support during chemotherapy<|>6)\n##\n(\"relationship\"<|>SHUSTER J<|>MARROW TRANSPLANT GROUP<|>Shuster J has contributed to the Marrow Transplant Group's research on pediatric cancer nutrition<|>6)\n##\n(\"relationship\"<|>DONALDSON SS<|>MARROW TRANSPLANT GROUP<|>Donaldson SS has provided insights to the Marrow Transplant Group on nutritional support<|>6)\n##\n(\"relationship\"<|>SEFCICK A<|>MARROW TRANSPLANT GROUP<|>Sefcick A has collaborated with the Marrow Transplant Group on studies regarding feeding in transplant recipients<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: and Marrow Transplant Group, Infectious Diseases Society of America, Society for healthcare Epidemiology of America, Association of Medical microbiology and Infectious Disease Canada, Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl 2009;15:1143e238.\n23. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogenic and autologous transplantation for\n---\n          Tema 41.      Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad)…                           671\n\n\n\n     haematological disease, solid tumors and immune                              requirements required for positive outcome. Pro-\n     disorders:    current    practice    in   Europe     in  1998.               cedures of the Annual Meeting of the American\n     Bone Marrow Transplant 1998; 21:1-7.                                         Society of Clinical Oncology 1997.\n24.  Allen SJ, Okoko B, Martínez E, Gregorio G, Dans                        36.   Young M, Stanford J, Walker DJ, Frost G. Prelimi-\n     LF. Probiotics for treating infectious diarrhea. Co-                         nary report of the efficacy of nasogastric feeding\n     chrane Database Syst Rev. 2003 (4):CD00304048.                               in allogenic adult bone marrow transplant pa-\n25.  Thompson TL, Duffy J. Nutritional support challen-                           tients. Original Communications of the Nutrition\n     ges in hematopoietic stem cell transplant patients.                          Society 1997.\n     NCP 2008; 23:533-46.                                                   37.   Bounous G, Ie Bel E, Shuster J. Dietary protection\n26.  RicKard KA, Baehner RL, Coates TD y cols. Suppor-                            during radiation therapy. Strahletherapie 1975;\n     tive nutritional intervention in pediatric cancer.                           149: 476-483.\n     Cancer Res 1982; 42(suppl): 766-773.                                   38.   Donaldson SS. Nutritional support as an adjunt to\n27.  Smith DE, Handy DJ, Holden CE y cols. An investi-                            radiation therapy. J Parenter Enteral Nutr 1984;\n     gation of supplementary nasogastric feeding in                               8:302-310.\n     malnourished children undergoing treatment for                         39.   Fossa SD, Lehne G, Heimdal K, Theodorsen L. Clini-\n     malignancy: results of a pilot study. Journal of Hu-                         cal and biochemical long-term toxicity after posto-\n     man Nutrition and Dietetics 1992; 5: 85-91.                                  perative cisplatin-based chemotherapy in patients\n28.  Seguy D, Duhamel A, Rejeb MB, Gomez E, Buhl                                  with low-stage testicular cancer. Oncology 1995;\n     ND, Bruno B, et al. Better outcome of patients un-                           52: 300-305.\n     dergoing enteral tube feeding after myeloablative                      40.   Evans TR, Harper CL, Beveridge IG. A randomised\n     conditioning for allogeneic stem cell transplanta-                           study to determine whether routine intravenous\n     tion. Transplantation 2012;94:287e94.                                        magnesium        supplements       are   necessary      in  pa-\n29.  Guièze R, Lemal R, Cabrespine A, Hermet E, Tour-                             tients receiving cisplatin chemotherapy with con-\n     nilhac O, Combal C, et al. Enteral versus parente-                           tinuous infusion 5-fluoruracil. Eur J Cancer 1995;\n     ral nutritional support in allogeneic haemato-                               31:174-178.\n     poietic stem-cell transplantation. Clin Nutr 2014;                     41.   Martín-Salces M, de Paz R, Canales MA, Mesejo A,\n     33:533e8.                                                                    Henández-Navarro          F.  Nutritional     recommenda-\n30.  Mulder PO, Bouman JG, Gietema JA, Van Rijsber-                               tions in hematopoietic stem cell transplantation.\n     gen H, Mulder NH, Van der Grest, De Vries EG.                                Nutrition 2008; 24: 769-775.\n     Hyperalimentation in autologous bone marrow                            42.   Mesejo A, Ordóñez J, Ortiz C. Artificial nutrition in\n     transplantation for solid tumours. Comparison of                             hematopoietic        stem    cell  transplantation.       Nutr\n     total Parenteral versus partial Parenteral plus ente-                        Hosp 2005; 20: 54-6.\n     ral nutrition. Cancer 1989; 64 (10): 2045-2052.                        43.   Lough M, Watkins R, Campbell M, Carr K, Burnett\n31.  Sefcick A, Anderton D, Byrne JL, Teahon K, Russell                           A, Shenkin A. Parenteral nutrition in bone marrow\n     NH. Naso-jejunal feeding in allogenic bone ma-                               transplantation. Clin Nutr 1990; 9(2): 97-101.\n     rrow transplant recipients:\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MARROW TRANSPLANT GROUP<|>ORGANIZATION<|>The Marrow Transplant Group is an organization focused on the research and guidelines for hematopoietic cell transplantation and its complications.)\n##\n(\"entity\"<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>ORGANIZATION<|>The Infectious Diseases Society of America is a professional organization that aims to improve the health of patients with infectious diseases through education and research.)\n##\n(\"entity\"<|>SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA<|>ORGANIZATION<|>The Society for Healthcare Epidemiology of America is an organization dedicated to the prevention of healthcare-associated infections and improving patient safety.)\n##\n(\"entity\"<|>ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA<|>ORGANIZATION<|>This association focuses on the advancement of medical microbiology and infectious diseases in Canada through research and education.)\n##\n(\"entity\"<|>CENTERS FOR DISEASE CONTROL AND PREVENTION<|>ORGANIZATION<|>The CDC is a national public health institute in the United States that focuses on disease control and prevention, including guidelines for various health conditions.)\n##\n(\"entity\"<|>HEMATOPOIETIC CELL TRANSPLANTATION<|>EVENT<|>Hematopoietic cell transplantation is a medical procedure used to treat various diseases, including cancers, by replacing damaged or diseased bone marrow with healthy cells.)\n##\n(\"entity\"<|>ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY<|>EVENT<|>This annual meeting is a significant event in the field of oncology, where professionals gather to discuss advancements in cancer treatment and research.)\n##\n(\"entity\"<|>NUTRITION SOCIETY<|>ORGANIZATION<|>The Nutrition Society is an organization that promotes the study and dissemination of nutrition science and its application to health and disease.)\n##\n(\"relationship\"<|>MARROW TRANSPLANT GROUP<|>CENTERS FOR DISEASE CONTROL AND PREVENTION<|>The Marrow Transplant Group collaborates with the CDC to develop guidelines for preventing infectious complications in transplant recipients<|>8)\n##\n(\"relationship\"<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>MARROW TRANSPLANT GROUP<|>The Infectious Diseases Society of America works with the Marrow Transplant Group to address infectious disease risks in transplant patients<|>7)\n##\n(\"relationship\"<|>SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA<|>MARROW TRANSPLANT GROUP<|>The Society for Healthcare Epidemiology of America collaborates with the Marrow Transplant Group to improve infection control practices in transplant settings<|>7)\n##\n(\"relationship\"<|>ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA<|>MARROW TRANSPLANT GROUP<|>The Association of Medical Microbiology and Infectious Disease Canada partners with the Marrow Transplant Group to enhance research on infectious diseases in transplant patients<|>6)\n##\n(\"relationship\"<|>HEMATOPOIETIC CELL TRANSPLANTATION<|>MARROW TRANSPLANT GROUP<|>The Marrow Transplant Group provides guidelines and research for hematopoietic cell transplantation procedures<|>9)\n##\n(\"relationship\"<|>ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY<|>MARROW TRANSPLANT GROUP<|>The Marrow Transplant Group presents findings and guidelines at the Annual Meeting of the American Society of Clinical Oncology<|>8)\n##\n(\"relationship\"<|>NUTRITION SOCIETY<|>MARROW TRANSPLANT GROUP<|>The Nutrition Society collaborates with the Marrow Transplant Group to address nutritional support in hematopoietic stem cell transplantation<|>7)\n<|COMPLETE|>"}]}